Koninklijke Philips Inventory 2010-2025 | PHG

Koninklijke Philips inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
  • Koninklijke Philips inventory for the quarter ending March 31, 2025 was $3.509B, a 19.57% decline year-over-year.
  • Koninklijke Philips inventory for 2024 was $3.461B, a 8.41% decline from 2023.
  • Koninklijke Philips inventory for 2023 was $3.778B, a 11.43% decline from 2022.
  • Koninklijke Philips inventory for 2022 was $4.266B, a 4.52% increase from 2021.
Koninklijke Philips Annual Inventory
(Millions of US $)
2024 $3,461
2023 $3,778
2022 $4,266
2021 $4,082
2020 $3,419
2019 $3,106
2018 $3,158
2017 $2,660
2016 $3,754
2015 $3,845
2014 $4,405
2013 $4,304
2012 $4,495
2011 $5,049
2010 $5,133
2009 $4,062
Koninklijke Philips Quarterly Inventory
(Millions of US $)
2025-03-31 $3,509
2024-06-30 $3,890
2023-06-30 $4,465
2023-03-31
2022-06-30 $4,363
2021-06-30 $3,886
2020-06-30 $3,516
2019-06-30 $3,352
2018-06-30 $3,220
2017-06-30 $2,821
2016-12-31 $3,754
2016-09-30 $4,193
2016-06-30 $4,167
2016-03-31 $3,973
2015-12-31 $3,845
2015-09-30 $4,463
2015-06-30 $4,395
2015-03-31 $4,420
2014-12-31 $4,405
2014-09-30 $5,280
2014-06-30 $4,991
2014-03-31 $4,727
2013-12-31 $4,304
2013-09-30 $5,076
2013-06-30 $4,831
2013-03-31 $4,796
2012-12-31 $4,495
2012-09-30 $5,094
2012-06-30 $5,106
2012-03-31 $5,007
2011-12-31 $5,049
2011-09-30 $5,768
2011-06-30 $5,410
2011-03-31 $4,846
2010-12-31 $5,133
2010-09-30 $5,362
2010-06-30 $5,013
2010-03-31 $4,577
2009-12-31 $4,062
2009-09-30 $4,711
2009-06-30 $4,380
2009-03-31 $4,360
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.709B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $219.828B 25.79
Boston Scientific (BSX) United States $156.585B 37.40
Stryker (SYK) United States $152.939B 31.98
EssilorLuxottica (ESLOY) France $137.925B 0.00
Medtronic (MDT) Ireland $117.956B 16.72
Lonza Group Ag (LZAGY) Switzerland $49.343B 0.00
Haleon (HLN) United Kingdom $43.576B 24.87
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.596B 16.90
Agilent Technologies (A) United States $33.957B 22.14
Terumo (TRUMY) Japan $25.643B 33.31
Insulet (PODD) United States $20.568B 80.74
Zimmer Biomet Holdings (ZBH) United States $18.989B 12.20
Baxter (BAX) United States $14.636B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.656B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.891B 23.98
Lantheus Holdings (LNTH) United States $5.010B 12.64
Perrigo (PRGO) Ireland $3.867B 9.80
Prestige Consumer Healthcare (PBH) United States $3.770B 16.84
Haemonetics (HAE) United States $3.587B 16.34
Envista Holdings (NVST) United States $3.515B 29.21
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.138B 23.14
LeMaitre Vascular (LMAT) United States $1.863B 41.65
QuidelOrtho (QDEL) United States $1.764B 12.14
AtriCure (ATRC) United States $1.645B 0.00
Acuren (TIC) United States $1.367B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.96
AdaptHealth (AHCO) United States $1.294B 13.14
Neogen (NEOG) United States $1.176B 15.06
Phibro Animal Health (PAHC) United States $1.172B 14.98
BioLife Solutions (BLFS) United States $1.063B 0.00
Curaleaf Holdings (CURLF) Canada $0.987B 0.00
InMode (INMD) Israel $0.919B 9.26
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Tilray Brands (TLRY) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
Valneva SE (VALN) France $0.648B 0.00
Owens & Minor (OMI) United States $0.608B 5.04
Evolus (EOLS) United States $0.598B 0.00
CeriBell (CBLL) United States $0.541B 0.00
Surmodics (SRDX) United States $0.524B 0.00
ZimVie (ZIMV) United States $0.524B 23.82
SNDL (SNDL) Canada $0.394B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.358B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.97
Quanterix (QTRX) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.310B 0.00
Sanuwave Health (SNWV) United States $0.306B 0.00
Aurora Cannabis (ACB) Canada $0.269B 79.67
Cerus (CERS) United States $0.260B 0.00
Omeros (OMER) United States $0.256B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.246B 20.77
Biote (BTMD) United States $0.239B 6.72
Verano Holdings (VRNOF) United States $0.238B 0.00
Brainsway (BWAY) Israel $0.227B 60.00
Canopy Growth (CGC) Canada $0.224B 0.00
Sanara MedTech (SMTI) United States $0.222B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.45
High Tide (HITI) Canada $0.184B 0.00
TriSalus Life Sciences (TLSI) United States $0.172B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.157B 0.00
TerrAscend (TSNDF) Canada $0.138B 0.00
FitLife Brands (FTLF) United States $0.120B 14.83
MacroGenics (MGNX) United States $0.105B 0.00
Jushi Holdings (JUSHF) United States $0.104B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.099B 12.77
Quipt Home Medical (QIPT) United States $0.093B 0.00
Apyx Medical (APYX) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Veru (VERU) United States $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.067B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
United-Guardian (UG) United States $0.039B 13.38
Nephros (NEPH) United States $0.038B 51.43
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00